Valuation: North China Pharmaceutical Company.Ltd

Market Cap 7.91B 1.18B 1.01B 943M 862M 1.63B 113B 1.64B 11.16B 4.34B 56.57B 4.42B 4.32B 187B P/E 2024
69.9x
P/E 2025 51.7x
Enterprise Value 17.58B 2.62B 2.24B 2.1B 1.92B 3.62B 250B 3.66B 24.81B 9.65B 126B 9.82B 9.61B 416B EV / Sales 2024
1.89x
EV / Sales 2025 2.07x
Free-Float
40.58%
Yield 2024
0.58%
Yield 2025 0.63%
1 day-6.11%
1 week-8.53%
Current month-4.36%
1 month-4.36%
3 months-1.28%
6 months-16.18%
Current year-16.64%
1 week 4.56
Extreme 4.56
5.22
1 month 4.56
Extreme 4.56
5.22
Current year 4.11
Extreme 4.11
6.07
1 year 4.11
Extreme 4.11
6.63
3 years 3.83
Extreme 3.83
7.46
5 years 3.83
Extreme 3.83
13.45
10 years 3.83
Extreme 3.83
20.24
Manager TitleAgeSince
Chief Executive Officer 55 28/11/2025
Director of Finance/CFO 46 10/04/2024
Investor Relations Contact 45 -
Director TitleAgeSince
Chairman 49 22/03/2016
Chairman 54 10/04/2023
Director/Board Member 53 23/04/2021
Date Insider Type Main position Quantity % Market Cap.
25/2/25 Buy

Chairman

1,600 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-6.11%-8.53%-29.62%-16.33% 1.25B
-0.67%+5.39%+79.33%+127.54% 1,119B
+1.04%+4.07%+53.04%+65.39% 651B
-0.17%+5.67%+27.45%+80.40% 468B
-1.38%+4.31%+41.64%+41.08% 374B
-0.52%+3.53%+24.32%+40.27% 302B
-1.06%+5.67%+1.19%+12.44% 259B
+1.03%+5.83%+53.86%+72.96% 238B
-0.53%+1.54%-17.77%-54.10% 208B
+0.42%+5.63%+28.55%+92.24% 181B
Average -0.81%+3.59%+26.20%+46.19% 380.11B
Weighted average by Cap. -0.16%+5.39%+45.68%+72.73%

Financials

2024 2025
Net sales 9.87B 1.47B 1.26B 1.18B 1.08B 2.03B 141B 2.05B 13.93B 5.42B 70.58B 5.51B 5.39B 234B 9.24B 1.37B 1.18B 1.1B 1.01B 1.9B 132B 1.92B 13.04B 5.07B 66.09B 5.16B 5.05B 219B
Net income 127M 18.89M 16.19M 15.14M 13.85M 26.13M 1.81B 26.41M 179M 69.68M 908M 70.92M 69.39M 3B 183M 27.23M 23.33M 21.83M 19.96M 37.66M 2.61B 38.06M 258M 100M 1.31B 102M 100M 4.33B
Net Debt 9.79B 1.46B 1.25B 1.17B 1.07B 2.01B 139B 2.04B 13.81B 5.37B 70.01B 5.47B 5.35B 232B 9.67B 1.44B 1.23B 1.15B 1.05B 1.99B 138B 2.01B 13.65B 5.31B 69.18B 5.4B 5.29B 229B
Logo North China Pharmaceutical Company.Ltd
North China Pharmaceutical Co Ltd is a China-based company primarily engaged in the research, development, production and sales of pharmaceutical products. The Company's main products include anti-infective drugs, nephrology and immunomodulatory drugs, biotechnology drugs, cardiovascular and cerebrovascular and immunomodulatory agents, vitamins and health consumer products, nervous and blood system drugs, pharmaceutical intermediates, anti-epidemic drugs, pesticides and Veterinary drugs. The Company is also engaged in pharmaceutical and other logistics trade pharmaceuticals. The Company's products are mainly used in chemical pharmaceuticals, modern biotechnology drugs, vitamins and health consumer products, bioagricultural and veterinary drugs and other fields. The Company mainly conducts its businesses in domestic and overseas markets.
Employees
9,972
Date Price Change Volume
24/08/26 CNY 4.610 -6.11% 37,113,130
21/08/26 CNY 4.910 -4.47% 30,827,784
20/08/26 CNY 5.140 +1.58% 29,397,277
19/08/26 CNY 5.060 -1.94% 30,406,512
18/08/26 CNY 5.160 +2.18% 35,076,975

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600812 Stock